BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25672727)

  • 21. Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential.
    You J; Youssef MMM; Santos JR; Lee J; Park J
    Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The microglial component of amyotrophic lateral sclerosis.
    Clarke BE; Patani R
    Brain; 2020 Dec; 143(12):3526-3539. PubMed ID: 33427296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
    Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Sasaki S; Iwata M; Morikawa S; Hirano A; Kobayashi M
    Neurodegener Dis; 2009; 6(3):118-26. PubMed ID: 19372705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
    Evans MC; Couch Y; Sibson N; Turner MR
    Mol Cell Neurosci; 2013 Mar; 53():34-41. PubMed ID: 23110760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
    Fontanilla CV; Wei X; Zhao L; Johnstone B; Pascuzzi RM; Farlow MR; Du Y
    Neuroscience; 2012 Mar; 205():185-93. PubMed ID: 22206942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
    Van den Bosch L
    Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis.
    Liu Z; Cheng X; Zhong S; Zhang X; Liu C; Liu F; Zhao C
    Front Neurosci; 2020; 14():575. PubMed ID: 32612503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?
    Cipollina G; Davari Serej A; Di Nolfi G; Gazzano A; Marsala A; Spatafora MG; Peviani M
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33113845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?
    Guidotti G; Scarlata C; Brambilla L; Rossi D
    Cells; 2021 Mar; 10(3):. PubMed ID: 33804386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New kid on the block: does histamine get along with inflammation in amyotrophic lateral sclerosis?
    Volonté C; Parisi C; Apolloni S
    CNS Neurol Disord Drug Targets; 2015; 14(5):677-86. PubMed ID: 25714965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
    Appel SH; Beers DR; Henkel JS
    Trends Immunol; 2010 Jan; 31(1):7-17. PubMed ID: 19879804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Looking to the Future of the Role of Macrophages and Extracellular Vesicles in Neuroinflammation in ALS.
    Carata E; Muci M; Di Giulio S; Mariano S; Panzarini E
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology.
    Lyon MS; Wosiski-Kuhn M; Gillespie R; Caress J; Milligan C
    Muscle Nerve; 2019 Jan; 59(1):10-22. PubMed ID: 29979464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: a therapeutic opportunity?
    Calvo A; Moglia C; Balma M; Chiò A
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):325-30. PubMed ID: 20406178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration.
    Niranjan R
    Neurochem Int; 2018 Nov; 120():13-20. PubMed ID: 30016687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogen Sulfide and Neuroinflammation.
    Kida K; Ichinose F
    Handb Exp Pharmacol; 2015; 230():181-9. PubMed ID: 26162835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The TGF-β System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis.
    Peters S; Zitzelsperger E; Kuespert S; Iberl S; Heydn R; Johannesen S; Petri S; Aigner L; Thal DR; Hermann A; Weishaupt JH; Bruun TH; Bogdahn U
    Front Neurol; 2017; 8():669. PubMed ID: 29326641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-β plasma levels and its role in amyotrophic lateral sclerosis.
    Duque T; Gromicho M; Pronto-Laborinho AC; de Carvalho M
    Med Hypotheses; 2020 Jun; 139():109632. PubMed ID: 32085981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocytic TGF-β1: detrimental factor in ALS.
    Endo F; Yamanaka K
    Oncotarget; 2015 Jun; 6(18):15728-9. PubMed ID: 26164079
    [No Abstract]   [Full Text] [Related]  

  • 40. Glia Crosstalk in Neuroinflammatory Diseases.
    Bernaus A; Blanco S; Sevilla A
    Front Cell Neurosci; 2020; 14():209. PubMed ID: 32848613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.